Form 10-Q CANCER GENETICS, INC For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
Cancer Genetics (CGIX) Tops Q1 EPS by 10c
May 12, 2015 7:32 AM EDTCancer Genetics (NASDAQ: CGIX) reported Q1 EPS of ($0.44), $0.10 better than the analyst estimate of ($0.54). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $3.91 million.
For earnings history and earnings-related data on Cancer Genetics (CGIX) click here.
... More